ASCL1 and glioblastoma: Importantly, forced ASCL1 in the mesenchymal subtype does not drive neuronal differentiation, but instead induces a neuroendocrine phenotype coupled with increased malignancy [162], which has important clinical implications for developing safe and effective interventions for glioblastoma.